You are here

A Safety Study For Prevenar 13 Among Chinese Children

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
School of Public Health at Fudan University
Shanghai, , 200032 China
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Seizures, Urticaria and Angioedema, Apnea, Fever
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
1-24 month
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

To be eligible for the main study, children in Yinzhou population-based EHR database must
be aged 1 to 24 months and receive at least one dose of 13vPnC between May 1st, 2017 and
July 24th, 2020 where the first dose is received before or on July 24th, 2020 since a 7-day
post-vaccination follow-up for each dose in each child receiving 13vPnC is needed. For the
prospective cohort in a sub-population of the main study, eligible children for the main
study must receive the first dose of 13vPnC between July 1st, 2018 and July 24th, 2020 and
an informed consent must be obtained from parents/legal guardians.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

There are no exclusion criteria for this study.

NCT03656939
Pfizer
Active, not recruiting
A Safety Study For Prevenar 13 Among Chinese Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now